Literature DB >> 8384129

Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms.

S N Shchelkunov1, V M Blinov, L S Sandakhchiev.   

Abstract

Analysis of variola virus nucleotide sequence revealed proteins belonging to several families which provide the virus with the possibility of overcoming the barriers of specific and non-specific host defence against viral infection. The complement-binding proteins, lymphokine-binding proteins, and serine protease inhibitors can be assigned to this type, as can the proteins providing the orthopoxviruses with resistance to interferon. The revealed differences between the genes (proteins) of variola and vaccinia viruses under study are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384129     DOI: 10.1016/0014-5793(93)80041-r

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Species-level identification of orthopoxviruses with an oligonucleotide microchip.

Authors:  Sergey Lapa; Maxim Mikheev; Sergei Shchelkunov; Vladimir Mikhailovich; Alexander Sobolev; Vladimir Blinov; Igor Babkin; Alexander Guskov; Elena Sokunova; Alexander Zasedatelev; Lev Sandakhchiev; Andrei Mirzabekov
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication.

Authors:  F Almazán; D C Tscharke; G L Smith
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories.

Authors:  C Upton; L Schiff; S A Rice; T Dowdeswell; X Yang; G McFadden
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  A mechanism for the inhibition of fever by a virus.

Authors:  A Alcamí; G L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.

Authors:  A A McIntosh; G L Smith
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity.

Authors:  A Alcamí; G L Smith
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Rescue of vaccinia virus lacking the E3L gene by mutants of E3L.

Authors:  H W Chang; L H Uribe; B L Jacobs
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  PSPP: a protein structure prediction pipeline for computing clusters.

Authors:  Michael S Lee; Rajkumar Bondugula; Valmik Desai; Nela Zavaljevski; In-Chul Yeh; Anders Wallqvist; Jaques Reifman
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.